Back to search

United Kingdom· GB-APID-13465911000001107

Zemplar 4microgram capsules

A paricalcitol product containing paricalcitol, registered in United Kingdom by AbbVie Ltd. The same ATC class is registered in 12 of our 19 countries.

ATC H05BX02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedZemplar 4microgram capsulesATCH05BX02REGISTER NO.GB-APID-1346591100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Paricalcitol is registered in 12 of 19 countries.

Countries holding a registration under ATC H05BX02 (paricalcitol), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 7 of them publish a price we can compare per daily dose

Paricalcitol · ATC H05BX02

12 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paricalcitol costs, country by country.

Normalised to the WHO defined daily dose (2 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Paricalcitol · price per daily dose (2 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$11.31
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Paricalcitol
Manufacturer
AbbVie Ltd
Country
United Kingdom (GB)
ATC code
H05BX02
ATC class
Paricalcitol
Defined daily dose
2 mcg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5013158776708

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

285 interactions on record for paricalcitol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Paricalcitol · interactions on record

285 records

  • 11 severe
  • 108 moderate
  • 166 info

Most severe, free to view

  • SucralfateA02BX02severe
  • ErgocalciferolA11CC01severe
  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paricalcitol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paricalcitol products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Paricalcitol Accord, Zemplar
  • Bulgaria · Тевапаривит
  • Cyprus · Rextol
  • Czechia · Paricalcitol Accord, Paricalcitol Agmed
  • Germany · Paricalcitol Accord, Paricalcitol Hexal
  • Denmark · Paricalcitol Pharmathen
  • Spain · Paricalcitol Accord, Paricalcitol Accordpharma
  • Finland · Paricalcitol Accord, Paricalcitol Alternova
  • Greece · Aricitol, Panozin
  • Croatia · Parkol, Zemplar
  • Hungary · Paricalcitol Fresenius, Paricalcitol Onkogen
  • Ireland · Paricalcitol Pinewood Laboratories, Zemplar
  • Italy · Paracalcitolo Mylan, Paracalcitolo Sandoz
  • Luxembourg · Porontazin
  • Netherlands · Paricalcitol Accord, Paricalcitol Heaton
  • Norway · Paricalcitol Alternova
  • Poland · Paricalcitol Fresenius
  • Portugal · Paricalcitol Accord, Paricalcitol Altan
  • Romania · Paricalcitol, Rextol
  • Sweden · Paricalcitol Accord, Paricalcitol Alternova
  • Slovenia · Zemplar
  • Slovakia · Paricalcitol Heaton, Zemplar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/38bcdcad-14ef-4e16-9e7d-950d0f853b1a
GET /v1/drugs/38bcdcad-14ef-4e16-9e7d-950d0f853b1a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "13465911000001107",
  "desc": "Zemplar 4microgram capsules (AbbVie Ltd)",
  "form": "Oral capsule",
  "vpid": "41767611000001108",
  "source": "dmd",
  "vtm_id": "777082005",
  "strength": "4 microgram",
  "substance": "Paricalcitol",
  "ingredient": "Paricalcitol",
  "supplier_code": "20741511000001103"
}

See everything about paricalcitol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.